Overview

Efalizumab for Eczema

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate a measurable improvement on a validated scale in a small population of adult patients with atopic dermatitis (eczema).

Phase:

Phase 2

Details

Lead Sponsor:

University of Medicine and Dentistry of New Jersey

Collaborator:

Genentech, Inc.

Treatments:

Antibodies, Monoclonal